In recent years, the disseminated intravascular coagulation (DIC) market is anticipated to grow rapidly during the forecast period owing to the increasing prevalence of cancer. As per the International Agency for Research on Cancer (IARC), the global burden of cancer is anticipated to increase to 27.5 million new cases along with 16.3 million deaths by 2040. Cancer is one of the major risk factor that for disseminated intravascular coagulation (DIC). Disseminated intravascular coagulation (DIC) is a hazardous condition in which blood clotting proteins become hyperactive.
